57:39
Handling Suspected Fraud and Data Fabrication in Clinical Studies
1:07:46
Development and Delivery of Pharmaceutical Products (CMC) - MaRS Best Practices
59:41
Leveraging Interim Analyses to Optimize Late Phase Clinical Trial Decision Making
2:03:01
Investigational New Drug Workshop
55:45